Cancer diagnosis with Positron Emission Tomography ; Development of a new tyrosine analogue
Cancer diagnosis with Positron Emission Tomography ; Development of a new tyrosine analogue
批准号:
16390349
负责人:
KUBOTA Kazuo
金额:
$7.44万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The aim of study is the development of a new amino acid analogue O-[11C]methyl-L-tyrosine (OMT) and its first clinical application to whole-body imaging as well as brain tumor imaging. OMT was firstly prepared with a high radiochemical yield by the methylation of L-tyrosine with [^<11>C]methyl triflate followed by HPLC purification (Iwata et al., 2002). Later, the simple automated method using the solid phase extraction without HPLC purification was developed for routine clinical use (Ishikawa et al., 2005).Seventeen patients (13 male, 4 female, mean age 69, range 46-89) of various types of cancer or suspected of cancer with 24 lesions were studied with OMT-PET. Sixteen patients have been studied with FDG-PET also within a week.Diagnostic accuracy for all lesions were calculated as follows : sensitivity of OMT 75% (12/16) and FDG 94% (15/16) ; specificity of OMT 75% (6/8) and FDG 43% (3/7) ; and accuracy of OMT 75% (18/24) and FDG 78% (18/23). Chronic xantomatous cholecystitis showed r … More ing like uptake with FDG, but no significant uptake with OMT. Tumor to background ratios (T/B ratios) of lung cancer and brain tumor were around 2.0. Mean SUV values of malignant and benign lesions with OMT-PET and FDG-PET were as follows : OMT malignant 2.26±1.44 (n=16), OMT benign 2.25±1.33 (n=8), FDG malignant 5.98±3.38 (n=16), FDG benign 4.79±2.64 (n=7). There were no significant differences between malignant and benign neither with FDG nor OMT.As the normal distribution, liver and pancreas uptake of OMT was mild, but urinary excretion was observed from early after injection. Normal brain uptake was lower than the liver, and slightly higher than the muscle. Kidney and urine in the bladder showed the highest activity. Results were summarized as follows;1. OMT uptake by tumor was tended lower than the FDG.2. OMT uptake by inflammation was tended lower than the FDG.3. In some tumors, such as esophageal cancer, gall bladder cancer, OMT-PET may be helpful to avoid false positive results that was derived by FDG uptake of active inflammation. Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy.
FDG-PET 延迟成像用于检测放化疗后头颈癌复发。
DOI:
--
发表时间:
2004
期刊:
European Journal of Nuclear Medicine 31
影响因子:
--
作者:
[Kubota K, Yokoyama J, Yamaguchi K, et al.]
通讯作者:
et al.
DOI:
10.1007/s12149-007-0039-6
发表时间:
2007-09-01
期刊:
ANNALS OF NUCLEAR MEDICINE
影响因子:
2.6
作者:
[Ito, Kimiteru, Kubota, Kazuo, Sasao, Yuki]
通讯作者:
Sasao, Yuki
DOI:
10.1111/j.1349-7006.2008.00834.x
发表时间:
2008-07-01
期刊:
CANCER SCIENCE
影响因子:
5.7
作者:
[Hori, Katsuyoshi, Furumoto, Shozo, Kubota, Kazuo]
通讯作者:
Kubota, Kazuo
Cold tuberculous abscess identified by FDG-PET.
FDG-PET 鉴别冷结核性脓肿。
DOI:
--
发表时间:
2005
期刊:
Annals of Nuclear Medicine Vol 19
影响因子:
--
作者:
[Yago Y, Yukihiro M, Kuroki H, Katsuragawa Y, Kubota K.]
通讯作者:
Kubota K.
Optimun pre-scan delay of F-18 FDG PET for characterization of the solitary pulmonary nodule
F-18 FDG PET 的最佳预扫描延迟用于表征孤立性肺结节
DOI:
--
发表时间:
2004
期刊:
影响因子:
--
作者:
[Kubota K, etnal., Kubota K.]
通讯作者:
Kubota K.
共 26 条
A study for the diagnosis of inflammatory diseases of joint and spine using FDG-PET; prospective and retrospective studies
-
批准号:22591362
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2010
-
负责人:KUBOTA Kazuo
-
依托单位:
In TOW SONG ERA the FUNDAMENTAL PROBLEM on THE CAPITALS
-
批准号:15520442
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2003
-
负责人:KUBOTA Kazuo
-
依托单位:
A new progress of physical therapy for the purpose of prevention of cerebrovascular and infeetious diseases
-
批准号:12832011
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:KUBOTA Kazuo
-
依托单位:
PREDICTION OF RADIOTHERAPEUTIC EFFECTS ON TUMOR USING POSITRON EMISSION TOMOGRAPHY
-
批准号:09470195
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.74万
-
财政年份:1997
-
负责人:KUBOTA Kazuo
-
依托单位:
Research project for predictive diagnosis of cancer recurrence using positron emission tomography.
-
批准号:06454320
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.71万
-
财政年份:1994
-
负责人:KUBOTA Kazuo
-
依托单位:
Development of cancer imaging correlated to metastatic potential using positron emission tomography
-
批准号:04557047
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$3.26万
-
财政年份:1992
-
负责人:KUBOTA Kazuo
-
依托单位:
A basic research for the prediction of tumore recurrence using positron emission tomography.
-
批准号:03454277
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.84万
-
财政年份:1991
-
负责人:KUBOTA Kazuo
-
依托单位:
Development of a New Radiotherapy Evaluation Method With Positron Emission Tomography
-
批准号:01570582
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.9万
-
财政年份:1989
-
负责人:KUBOTA Kazuo
-
依托单位:
海外基金